RxDoctor Payments Data

Jagdeep Bijwadia, MD

Pulmonary Disease · Rochester, MNNPI 1861468639

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,322 of the $53,799 with a category attached, or 97.3%. Resmed Corp accounts for 95.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $45,743 and has fallen 86.3% since, to $6,246 in 2025. Among pulmonary disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,799in general payments, 2019–2025

Across 22 payments — averaging $2445.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Resmed Corp$51K
  • Inspire Medical Systems, Inc.$1K
  • Itamar Medical Inc$716
  • Harmony Biosciences LLC$179
  • Respire Medical Holdings LLC$117
  • Philips North America LLC$32
  • plus $16 from 1 others
$41,400in research payments, 2019–2025

Across 4 payments — averaging $10,350 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Resmed Corp$41K

What the payments were for

  • Consulting fees$52,32297%
  • Food & beverage$1,4773%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Resmed Corp8$51,393
Inspire Medical Systems, Inc.6$1,346
Itamar Medical Inc4$716
Harmony Biosciences LLC1$179
Respire Medical Holdings LLC1$117
Philips North America LLC1$32
AstraZeneca1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,799 in reported general payments places this provider in the 95th percentile of 261 pulmonary disease providers in Minnesota.

See all pulmonary disease providers in Minnesota

Medicare billing

Part B allowed, 2024
$19,537
Medicare patients
160
Services billed
196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →